AFP and hepatocellular carcinoma: Japanese clinical practice guidelines for HCC propose the use of serum biomarkers, alpha-fetoprotein (AFP), and protein induced by vitamin K absence or antagonist-II (PIVKA-II, also known as des-γ-carboxy prothrombin (DCP)), for routine follow-up of patients with chronic HBV infection [4].